
Bafna Pharmaceuticals Limited – NSE:BAFNAPH.NS
Bafna Pharmaceuticals Limited stock price today
Bafna Pharmaceuticals Limited stock price monthly change
Bafna Pharmaceuticals Limited stock price quarterly change
Bafna Pharmaceuticals Limited stock price yearly change
Bafna Pharmaceuticals Limited key metrics
Market Cap | 1.95B |
Enterprise value | 2.20B |
P/E | 29.57 |
EV/Sales | 2.50 |
EV/EBITDA | 18.93 |
Price/Sales | 2.42 |
Price/Book | 3.24 |
PEG ratio | -2.50 |
EPS | 3.11 |
Revenue | 1.52B |
EBITDA | 141.18M |
Income | 73.48M |
Revenue Q/Q | -2.00% |
Revenue Y/Y | 32.17% |
Profit margin | 5.62% |
Oper. margin | 2.29% |
Gross margin | 33.7% |
EBIT margin | 2.29% |
EBITDA margin | 9.26% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBafna Pharmaceuticals Limited stock price history
Bafna Pharmaceuticals Limited stock forecast
Bafna Pharmaceuticals Limited financial statements
Jun 2023 | 419.47M | 63.51M | 15.14% |
---|---|---|---|
Sep 2023 | 406.78M | 24.83M | 6.11% |
Dec 2023 | 284.42M | -29.42M | -10.35% |
Mar 2024 | 413.98M | 14.55M | 3.52% |
Jun 2023 | 0 | 0 | |
---|---|---|---|
Sep 2023 | 1348710000 | 525.05M | 38.93% |
Dec 2023 | 0 | 0 | |
Mar 2024 | 1476816000 | 652.27M | 44.17% |
Mar 2023 | 30.50M | 0 | 0 |
---|---|---|---|
Jun 2023 | 24.25M | 0 | 0 |
Sep 2023 | 24.82M | 0 | 0 |
Dec 2023 | 25.41M | 0 | 0 |
Bafna Pharmaceuticals Limited alternative data
Aug 2023 | 320 |
---|---|
Sep 2023 | 320 |
Oct 2023 | 588 |
Nov 2023 | 588 |
Dec 2023 | 588 |
Jan 2024 | 588 |
Feb 2024 | 588 |
Mar 2024 | 588 |
Apr 2024 | 588 |
May 2024 | 588 |
Jun 2024 | 588 |
Jul 2024 | 588 |
Bafna Pharmaceuticals Limited other data
Insider | Compensation |
---|---|
Mr. Bansilal Mahaveer Chand Bafna (1961) Chief Executive Officer | $1,250,000 |
-
What's the price of Bafna Pharmaceuticals Limited stock today?
One share of Bafna Pharmaceuticals Limited stock can currently be purchased for approximately $151.3.
-
When is Bafna Pharmaceuticals Limited's next earnings date?
Unfortunately, Bafna Pharmaceuticals Limited's (BAFNAPH.NS) next earnings date is currently unknown.
-
Does Bafna Pharmaceuticals Limited pay dividends?
No, Bafna Pharmaceuticals Limited does not pay dividends.
-
How much money does Bafna Pharmaceuticals Limited make?
Bafna Pharmaceuticals Limited has a market capitalization of 1.95B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 79.08% to 1.52B US dollars.
-
What is Bafna Pharmaceuticals Limited's stock symbol?
Bafna Pharmaceuticals Limited is traded on the NSE under the ticker symbol "BAFNAPH.NS".
-
What is Bafna Pharmaceuticals Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Bafna Pharmaceuticals Limited?
Shares of Bafna Pharmaceuticals Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Bafna Pharmaceuticals Limited's key executives?
Bafna Pharmaceuticals Limited's management team includes the following people:
- Mr. Bansilal Mahaveer Chand Bafna Chief Executive Officer(age: 64, pay: $1,250,000)
-
How many employees does Bafna Pharmaceuticals Limited have?
As Jul 2024, Bafna Pharmaceuticals Limited employs 588 workers.
-
When Bafna Pharmaceuticals Limited went public?
Bafna Pharmaceuticals Limited is publicly traded company for more then 12 years since IPO on 12 Nov 2012.
-
What is Bafna Pharmaceuticals Limited's official website?
The official website for Bafna Pharmaceuticals Limited is bafnapharma.com.
-
How can i contact Bafna Pharmaceuticals Limited?
Bafna Pharmaceuticals Limited can be reached via phone at +91 44 4267 7555.
Bafna Pharmaceuticals Limited company profile:

Bafna Pharmaceuticals Limited
bafnapharma.comNSE
363
Drug Manufacturers - Specialty & Generic
Healthcare
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.
Chennai, 600001
:
ISIN: INE878I01022
CUSIP: Y0538A127